Fig. 4From: Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in EuropeOverall use of concomitant targeted therapies and complementary treatments to manage chemotherapy side effects. Abbreviations: HT, hormone therapy; Rx, prescriptions; TT, targeted therapy. *Data presented for first line of chemotherapy treatment in each cohortBack to article page